Patent · US Active

In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein

US9500659B2 · kind B2 · utility

3Cited by
1References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2012
Grant dateNov 22, 2016
Priority date
Expiry dateNov 29, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/32
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An immunoassay for the quantification of fragments having an N- or a C-terminal neo-epitope formed by cleavage of a titin protein by a proteinase is provided. The immunoassay includes the steps of contacting a sample with an antibody specifically binding to the N- or C-terminal neo-epitope of the fragments and determining the level of binding.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.